Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Modified escalated BEACOPP as salvage chemotherapy in classic Hodgkin lymphoma.

× No keyword cloud information.

8 in total

1. Therapies for relapsed Hodgkin lymphoma: transplant and non-transplant approaches including immunotherapy.

Authors: Nancy L Bartlett
Journal: Hematology Am Soc Hematol Educ Program Date: 2005

2. Is there a role for BEACOPP (bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, prednisone) in relapsed Hodgkin lymphoma?

Authors: Dennis A Eichenauer; Andreas Engert
Journal: Leuk Lymphoma Date: 2009-11

3. New prognostic score based on treatment outcome of patients with relapsed Hodgkin's lymphoma registered in the database of the German Hodgkin's lymphoma study group.

Authors: Andreas Josting; Jeremy Franklin; Michael May; Peter Koch; Maria K Beykirch; Juergen Heinz; Christian Rudolph; Volker Diehl; Andreas Engert
Journal: J Clin Oncol Date: 2002-01-01 Impact factor: 44.544

4. Granulocyte colony-stimulating factor (G-CSF) dose-dependent efficacy in peripheral blood stem cell mobilization in patients who had failed initial mobilization with chemotherapy and G-CSF.

Authors: A K Lie; C H Hui; T Rawling; P G Dyson; D Thorp; J Benic; C M Rawling; I Toogood; N Horvath; P J Simmons; L B To
Journal: Bone Marrow Transplant Date: 1998-11 Impact factor: 5.483

5. Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.

Authors: Andreas Engert; Volker Diehl; Jeremy Franklin; Andreas Lohri; Bernd Dörken; Wolf-Dieter Ludwig; Peter Koch; Mathias Hänel; Michael Pfreundschuh; Martin Wilhelm; Lorenz Trümper; Walter-Erich Aulitzky; Martin Bentz; Mathias Rummel; Orhan Sezer; Hans-Konrad Müller-Hermelink; Dirk Hasenclever; Markus Löffler
Journal: J Clin Oncol Date: 2009-08-24 Impact factor: 44.544

6. Efficacy of the BEACOPP regimen in refractory and relapsed Hodgkin lymphoma.

Authors: Elena Cavalieri; Angela Matturro; Giorgia Annechini; Federico De Angelis; Natalia Frattarelli; Fabiana Gentilini; Lavinia Grapulin; Mikael Sacco; Fabio Torelli; Marco Vignetti; Franco Mandelli; Robin Foà; Alessandro Pulsoni
Journal: Leuk Lymphoma Date: 2009-11

7. A phase II study of plerixafor (AMD3100) plus G-CSF for autologous hematopoietic progenitor cell mobilization in patients with Hodgkin lymphoma.

Authors: Amanda Cashen; Sandra Lopez; Feng Gao; Gary Calandra; Ron MacFarland; Karin Badel; John DiPersio
Journal: Biol Blood Marrow Transplant Date: 2008-11 Impact factor: 5.742

8. BEACOPP: an intensified chemotherapy regimen in advanced Hodgkin's disease. The German Hodgkin's Lymphoma Study Group.

Authors: V Diehl; M Sieber; U Rüffer; B Lathan; D Hasenclever; M Pfreundschuh; M Loeffler; D Lieberz; P Koch; M Adler; H Tesch
Journal: Ann Oncol Date: 1997-02 Impact factor: 32.976

8 in total